Abstract
Following on from the NASA twins’ study, there has been a tremendous interest in the use of omics techniques in spaceflight. Individual space agencies, NASA's GeneLab, JAXA's ibSLS, and the ESA-funded Space Omics Topical Team and the International Standards for Space Omics Processing (ISSOP) groups have established several initiatives to support this growth. Here, we present recommendations from the Space Omics Topical Team to promote standard application of space omics in Europe. We focus on four main themes: i) continued participation in and coordination with international omics endeavors, ii) strengthening of the European space omics infrastructure including workforce and facilities, iii) capitalizing on the emerging opportunities in the commercial space sector, and iv) capitalizing on the emerging opportunities in human subjects research.
Original language | English |
---|---|
Article number | 107289 |
Journal | iScience |
Volume | 26 |
Issue number | 9 |
DOIs | |
State | Published - 15 Sep 2023 |
ASJC Scopus subject areas
- General
Access to Document
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: iScience, Vol. 26, No. 9, 107289, 15.09.2023.
Research output › peer-review
TY - JOUR
T1 - Enhancing European capabilities for application of multi-omics studies in biology and biomedicine space research
AU - Manzano, Aránzazu
AU - Weging, Silvio
AU - Bezdan, Daniela
AU - Borg, Joseph
AU - Cahill, Thomas
AU - Carnero-Diaz, Eugénie
AU - Cope, Henry
AU - Deane, Colleen S.
AU - Etheridge, Timothy
AU - Giacomello, Stefania
AU - Hardiman, Gary
AU - Leys, Natalie
AU - Madrigal, Pedro
AU - Mastroleo, Felice
AU - Medina, F. Javier
AU - Mieczkowski, Jakub
AU - Fernandez-Rojo, Manuel A.
AU - Siew, Keith
AU - Szewczyk, Nathaniel J.
AU - Walsh, Stephen B.
AU - Silveira, Willian A. da
AU - Herranz, Raúl
N1 - Score=10 Funding Information: All listed authors are members of the ESA Space Omics Topical Team, funded by the ESA grant/contract 4000131202/20/NL/PG/pt “Space Omics: Toward an integrated ESA/NASA –omics database for spaceflight and ground facilities experiments” awarded to RH, which was the main funding source for this work. Individual authors also acknowledge support from: the Horizon Center for Doctoral Training at the University of Nottingham [UKRI grant no. EP/S023305/1] to H.C. the Medical Research Council part of a Skills Development Fellowship [grant number MR/T026014/1] awarded to C.S.D.; the Spanish Comunidad Autonoma de Madrid TALENTO Modalidad-1 program project 2020-5A_BIO-19724 to M.A.F.R.; the Spanish National Research Council Grant 2021AEP135 to F.J.M. & R.H. the Swedish Research Council VR grant 2020-04864 to S.G. and the French Centre National d'Etudes Spatiales grant DAR 2020-4800001004, 2021-4800001117 to E.C.D. This research was also funded in part by the Wellcome Trust [110182/Z/15/Z] to K.S. N.J.S. acknowledges the support of the Osteopathic Heritage Foundation through funding for the Osteopathic Heritage Foundation Ralph S. Licklider, D.O. Research Endowment in the Heritage College of Osteopathic Medicine. For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. Conceptualization and methodology, A.M. S.W. and R.H.; original draft preparation, A.M. S.W. and R.H.; subsection contributions, review, and editing, all authors; academic English review, C.S.D. K.S. and S.B.W.; project administration and editing, S.G. D.B. N.J.S. W.d.S. and R.H.; funding acquisition, R.H. All authors have read and agreed to the published version of the manuscript. F.M. is CEO/Co-Founder at Genegoggle, D.B. is a cofounder of Poppy Health, Inc. and CSO of Yuri Gravity GmbH and declares affiliations at the NGS Competence Center Tübingen (NCCT), University of Tübingen, Tübingen and Yuri Gravity, Meckenbeuren, Germany. M.F.R. declares additional affiliation at Diamantina Institute, The University of Queensland, St Lucia, Queensland 4072, Australia. S.G. is a scientific consultant of 10x Genomics. One or more of the authors of this paper self-identifies as an underrepresented ethnic minority in their field of research or within their geographical location. One or more of the authors of this paper self-identifies as a gender minority in their field of research. One or more of the authors of this paper self-identifies as a member of the LGBTQIA+ community. We avoided “helicopter science” practices by including the participating local contributors from the region where we conducted the research as authors on the paper. Funding Information: All listed authors are members of the ESA Space Omics Topical Team, funded by the ESA grant/contract 4000131202/20/NL/PG/pt “Space Omics: Toward an integrated ESA/NASA –omics database for spaceflight and ground facilities experiments” awarded to RH, which was the main funding source for this work. Individual authors also acknowledge support from: the Horizon Center for Doctoral Training at the University of Nottingham [ UKRI grant no. EP/S023305/1 ] to H.C., the Medical Research Council part of a Skills Development Fellowship [grant number MR/T026014/1 ] awarded to C.S.D.; the Spanish Comunidad Autonoma de Madrid TALENTO Modalidad-1 program project 2020-5A_BIO-19724 to M.A.F.R.; the Spanish National Research Council Grant 2021AEP135 to F.J.M. & R.H., the Swedish Research Council VR grant 2020-04864 to S.G. and the French Centre National d'Etudes Spatiales grant DAR 2020-4800001004 , 2021-4800001117 to E.C.D. This research was also funded in part by the Wellcome Trust [ 110182/Z/15/Z ] to K.S. N.J.S. acknowledges the support of the Osteopathic Heritage Foundation through funding for the Osteopathic Heritage Foundation Ralph S. Licklider, D.O., Research Endowment in the Heritage College of Osteopathic Medicine . For the purpose of open access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript version arising from this submission. Publisher Copyright: © 2023 The Authors
PY - 2023/9/15
Y1 - 2023/9/15
N2 - Following on from the NASA twins’ study, there has been a tremendous interest in the use of omics techniques in spaceflight. Individual space agencies, NASA's GeneLab, JAXA's ibSLS, and the ESA-funded Space Omics Topical Team and the International Standards for Space Omics Processing (ISSOP) groups have established several initiatives to support this growth. Here, we present recommendations from the Space Omics Topical Team to promote standard application of space omics in Europe. We focus on four main themes: i) continued participation in and coordination with international omics endeavors, ii) strengthening of the European space omics infrastructure including workforce and facilities, iii) capitalizing on the emerging opportunities in the commercial space sector, and iv) capitalizing on the emerging opportunities in human subjects research.
AB - Following on from the NASA twins’ study, there has been a tremendous interest in the use of omics techniques in spaceflight. Individual space agencies, NASA's GeneLab, JAXA's ibSLS, and the ESA-funded Space Omics Topical Team and the International Standards for Space Omics Processing (ISSOP) groups have established several initiatives to support this growth. Here, we present recommendations from the Space Omics Topical Team to promote standard application of space omics in Europe. We focus on four main themes: i) continued participation in and coordination with international omics endeavors, ii) strengthening of the European space omics infrastructure including workforce and facilities, iii) capitalizing on the emerging opportunities in the commercial space sector, and iv) capitalizing on the emerging opportunities in human subjects research.
KW - NASA
KW - Space omics
KW - Emerging commercial space sector
KW - Human subjects
KW - ESA
KW - ISSOP
KW - Genomics
KW - Proteomics
KW - Space medicine
KW - Space sciences
UR - http://www.scopus.com/inward/record.url?scp=85167839278&partnerID=8YFLogxK
U2 - 10.1016/j.isci.2023.107289
DO - 10.1016/j.isci.2023.107289
M3 - Article
SN - 2589-0042
VL - 26
JO - iScience
JF - iScience
IS - 9
M1 - 107289
ER -